BackAdamis Pharmaceuticals Overview

Adamis Pharmaceuticals Total Assets

Latest total assets for ADMP: $9B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$8.96B
73700.77% YoYΔ $8.95B vs prior year quarter

Peer average / median

Loading

Adamis Pharmaceuticals Total Assets History

Loading

Adamis Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Adamis Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Adamis Pharmaceuticals (ADMP) FAQ

As of the most recent data (September 2023), ADMP shows a total assets of $9B. That compares with $12M in the prior-year period — up 73700.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADMP's total assets is now $9B (was $12M) — a 73700.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Adamis Pharmaceuticals is outperforming or lagging.

Tracking ADMP's total assets over time shows whether Adamis Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $9B That compares with $12M in the prior-year period — up 73700.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Adamis Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $9B) with ownership activity and broader fundamentals.

Adamis Pharmaceuticals's total assets is $9B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.